Boryung Pharm Q1 net income down 6.1 pct. to 8.3 bln won
All News
13:26 April 24, 2020
SEOUL, April 24 (Yonhap) -- Boryung Pharm Co. on Friday reported its first-quarter net income of 8.3 billion won (US$ 6.7 million), down 6.1 percent from a year earlier.
Operating income for the January-March period was 13.4 billion won, up 42.1 percent from a year ago, the company said in a regulatory filing. Revenue rose 13 percent to 134.2 billion won.
※ This article was generated by Yonhap's proprietary algorithm using data from Yonhap Infomax and Korea Exchange(KRX).
(END)
Issue Keywords
Most Liked
-
S. Korea to allow online permit-free entry for tourists from 22 nations to spur spending -
Opposition leader calls on Yoon to reject imports of products from Japan's Fukushima -
DP leader says Yoon should have stormed out of summit with Japan if Dokdo issue raised -
One-third of senior public officials have over 2 bln won in personal wealth: data
-
Actor Yoo Ah-in appears for questioning over alleged drug use
Most Saved
-
S. Korea to allow online permit-free entry for tourists from 22 nations to spur spending -
Grandson of ex-President Chun apprehended at Incheon Int'l Airport over drug use -
One-third of senior public officials have over 2 bln won in personal wealth: data
-
Actor Yoo Ah-in appears for questioning over alleged drug use -
Change seen among Japanese right wing favoring restoration of ties with S. Korea: envoy
-
Top U.S. general cancels plan to visit S. Korea due to time restraints: his office -
N.K. leader's sister accuses Zelenskyy of gambling with Ukraine's destiny -
Actors in Netflix series 'The Glory' dating: agencies -
(LEAD) Grandson of ex-President Chun apologizes to victims of 1980 democracy rising -
(2nd LD) S. Korea's exports down for 6th month in March on falling chip demand
